Chris Letkewicz concentrates his practice in representing a broad range of clients in high stakes healthcare and complex commercial litigation matters in federal and state courts across the country. Chris has an extensive track record of obtaining dismissals, summary judgment, appellate court affirmances of favorable trial court judgments and favorable settlements for clients.
Some of Chris’s most notable matters include:
- Represented Fortune 100 technology company against breach of contract claim seeking nine-figure damages. Helped obtain a business resolution on the eve of trial after successfully barring opposing party’s expert and obtaining favorable admissions from opponent’s witnesses in depositions.
- Represented major healthcare system in multi-million-dollar breach of employment contract claim brought by physician who had his hospital privileges terminated. Authored brief on an issue of first impression that persuaded a unanimous Illinois Supreme Court that healthcare system was immune from damages under the Illinois Hospital Licensing Act.
- Represented concessionaire in a constitutional challenge to a 75-year, billion-dollar public-private partnership contract related to a major city’s parking meter system. Helped secure summary judgment in trial court that was affirmed by the state’s appellate court.
- Represented major healthcare system in connection with multiple DEA investigations and compliance issues related to controlled substances diversions.
- Represented Fortune 50 financial institution in multi-million-dollar contract and tort dispute. Helped obtain summary judgment after two years of discovery that was unanimously affirmed by the 7th Circuit.
Chris is also actively involved in the firm’s pro bono practice. Recently, Chris persuaded the Board of Immigration Appeals to take the rare step of reversing the Immigration Court’s denial of asylum and granting asylum outright to a gay Senegalese man who was the victim of repeated physical attacks and death threats on account of his sexual orientation.